- Home
- CSGP vs IQV Comparison
CSGP vs IQV Comparison
Compare CSGP & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSGP
- IQV
- Stock Information
- Founded
- CSGP 1987
- IQV 1982
- Country
- CSGP United States
- IQV United States
- Employees
- CSGP N/A
- IQV N/A
- Industry
- CSGP Business Services
- IQV Biotechnology: Commercial Physical & Biological Resarch
- Sector
- CSGP Consumer Discretionary
- IQV Health Care
- Exchange
- CSGP Nasdaq
- IQV Nasdaq
- Market Cap
- CSGP 32.6B
- IQV 36.4B
- IPO Year
- CSGP 1998
- IQV 2013
- Fundamental
- Price
- CSGP $67.52
- IQV $210.46
- Analyst Decision
- CSGP Buy
- IQV Buy
- Analyst Count
- CSGP 14
- IQV 18
- Target Price
- CSGP $94.85
- IQV $237.89
- AVG Volume (30 Days)
- CSGP 4.3M
- IQV 1.8M
- Earning Date
- CSGP 10-28-2025
- IQV 10-28-2025
- Dividend Yield
- CSGP N/A
- IQV N/A
- EPS Growth
- CSGP N/A
- IQV N/A
- EPS
- CSGP 0.05
- IQV 7.30
- Revenue
- CSGP $3,056,500,000.00
- IQV $15,904,000,000.00
- Revenue This Year
- CSGP $20.75
- IQV $6.14
- Revenue Next Year
- CSGP $18.10
- IQV $5.28
- P/E Ratio
- CSGP $1,409.68
- IQV $28.82
- Revenue Growth
- CSGP 14.61
- IQV 3.85
- 52 Week Low
- CSGP $63.82
- IQV $134.65
- 52 Week High
- CSGP $97.43
- IQV $225.91
- Technical
- Relative Strength Index (RSI)
- CSGP 25.65
- IQV 53.25
- Support Level
- CSGP $66.41
- IQV $207.01
- Resistance Level
- CSGP $70.63
- IQV $212.68
- Average True Range (ATR)
- CSGP 2.41
- IQV 5.91
- MACD
- CSGP -0.38
- IQV -1.58
- Stochastic Oscillator
- CSGP 24.92
- IQV 21.88
About CSGP CoStar Group Inc.
CoStar Group is a leading provider of commercial real estate data and marketplace listing platforms. Its data offering contains in-depth analytical information on over 5 million commercial real estate properties related to various subsectors including office, retail, hotels, multifamily, healthcare, industrial, self-storage, and data centers. It operates many flagship brands such as CoStar Suite, LoopNet, Apartments.com, BizBuySell, and Lands of America, with more than 80% of its revenue classified as subscription-based. The company recently expanded its presence in Canada, the United Kingdom, Spain, and France.
About IQV IQVIA Holdings Inc.
Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.